chr16-85922065-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002163.4(IRF8):​c.*783C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.397 in 152,172 control chromosomes in the GnomAD database, including 12,308 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 12292 hom., cov: 33)
Exomes 𝑓: 0.38 ( 16 hom. )

Consequence

IRF8
NM_002163.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.408

Publications

36 publications found
Variant links:
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
IRF8 Gene-Disease associations (from GenCC):
  • Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Illumina
  • immunodeficiency 32B
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.444 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF8NM_002163.4 linkc.*783C>T 3_prime_UTR_variant Exon 9 of 9 ENST00000268638.10 NP_002154.1 Q02556
IRF8NM_001363907.1 linkc.*783C>T 3_prime_UTR_variant Exon 9 of 9 NP_001350836.1
IRF8NM_001363908.1 linkc.*783C>T 3_prime_UTR_variant Exon 7 of 7 NP_001350837.1
IRF8XM_047434052.1 linkc.*783C>T 3_prime_UTR_variant Exon 10 of 10 XP_047290008.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF8ENST00000268638.10 linkc.*783C>T 3_prime_UTR_variant Exon 9 of 9 1 NM_002163.4 ENSP00000268638.4 Q02556

Frequencies

GnomAD3 genomes
AF:
0.397
AC:
60291
AN:
151896
Hom.:
12261
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.449
Gnomad AMI
AF:
0.260
Gnomad AMR
AF:
0.315
Gnomad ASJ
AF:
0.344
Gnomad EAS
AF:
0.389
Gnomad SAS
AF:
0.245
Gnomad FIN
AF:
0.480
Gnomad MID
AF:
0.396
Gnomad NFE
AF:
0.387
Gnomad OTH
AF:
0.386
GnomAD4 exome
AF:
0.380
AC:
60
AN:
158
Hom.:
16
Cov.:
0
AF XY:
0.386
AC XY:
34
AN XY:
88
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.404
AC:
55
AN:
136
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.214
AC:
3
AN:
14
Other (OTH)
AF:
0.333
AC:
2
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.397
AC:
60376
AN:
152014
Hom.:
12292
Cov.:
33
AF XY:
0.396
AC XY:
29384
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.450
AC:
18646
AN:
41448
American (AMR)
AF:
0.315
AC:
4805
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.344
AC:
1194
AN:
3468
East Asian (EAS)
AF:
0.390
AC:
2019
AN:
5182
South Asian (SAS)
AF:
0.246
AC:
1185
AN:
4816
European-Finnish (FIN)
AF:
0.480
AC:
5065
AN:
10556
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.387
AC:
26282
AN:
67972
Other (OTH)
AF:
0.393
AC:
829
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1872
3744
5616
7488
9360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.385
Hom.:
47425
Bravo
AF:
0.390
Asia WGS
AF:
0.350
AC:
1216
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.5
DANN
Benign
0.73
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1044873; hg19: chr16-85955671; API